Individual Patient Expanded Access IND to Evaluate the Safety and Preliminary Efficacy of Autologous HB-adMSCs for the Treatment of Stroke
Latest Information Update: 21 Nov 2022
At a glance
- Drugs Autologous adipose derived mesenchymal stem cells Hope Biosciences (Primary)
- Indications Spinal cord injuries
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Acronyms SCI04
Most Recent Events
- 02 Jun 2021 New trial record